These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8511876)
1. [Activity of 5'-nucleotidase from thymus and tumors upon administering bradykinin to tumor-bearing mice]. Sukhanova GA; Potanova GV; Narbutovich SA Vopr Med Khim; 1993; 39(2):13-5. PubMed ID: 8511876 [TBL] [Abstract][Full Text] [Related]
2. Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice. Drake WP; Kopyta LP; Levy CC; Mardiney MR Cancer Res; 1975 Feb; 35(2):322-4. PubMed ID: 1053698 [TBL] [Abstract][Full Text] [Related]
3. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract. Shanker A; Singh SM Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840 [TBL] [Abstract][Full Text] [Related]
4. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Wu J; Akaike T; Maeda H Cancer Res; 1998 Jan; 58(1):159-65. PubMed ID: 9426072 [TBL] [Abstract][Full Text] [Related]
5. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624 [TBL] [Abstract][Full Text] [Related]
6. Aminotransferase activities and involution of the thymus in rats bearing AH 130 tumors. Isohashi F; Tsukanaka K; Terada M; Nakanishi Y; Tani S; Sakamoto Y Cancer Res; 1980 Mar; 40(3):877-81. PubMed ID: 6110478 [TBL] [Abstract][Full Text] [Related]
8. [The effect of Leu- and Met-enkephalins on the adenosine deaminase and 5'-nucleotidase activities of the lymphocytes under conditions of stress stimulation of metastasis]. Nadiradze ZO; Uamnskiĭ VIu; Shmal'ko IuP; Gachechiladze AG Fiziol Zh (1978); 1991; 37(2):54-60. PubMed ID: 2055328 [TBL] [Abstract][Full Text] [Related]
9. Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy. Emerich DF; Snodgrass P; Dean RL; Lafreniere D; Agostino M; Wiens T; Xiong H; Hasler B; Marsh J; Pink M; Kim BS; Bartus RT J Pharmacol Exp Ther; 2001 Feb; 296(2):623-31. PubMed ID: 11160651 [TBL] [Abstract][Full Text] [Related]
10. [Enzymes of adenosine metabolism in lymphocytes and the functional state of the sympatho-adrenal system in tumor processes]. Umanskiĭ VIu; Shmal'ko IuP Ukr Biokhim Zh (1978); 1986; 58(2):45-50. PubMed ID: 3010522 [TBL] [Abstract][Full Text] [Related]
11. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice. Beuth J; Schierholz JM; Ko HL; Braun JM In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237 [TBL] [Abstract][Full Text] [Related]
12. Characterization of thymocyte subpopulations by enzymatic markers. Livne PM; Sidi Y; Trainin N; Sperling O Thymus; 1983 Sep; 5(5-6):393-7. PubMed ID: 6318405 [TBL] [Abstract][Full Text] [Related]
13. A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth. Ueda Y; Yamagishi T; Samata K; Ikeya H; Hirayama N; Okazaki T; Nishihara S; Arai K; Yamaguchi S; Shibuya M; Nakaike S; Tanaka M Cancer Chemother Pharmacol; 2004 Jul; 54(1):16-24. PubMed ID: 15064856 [TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Luo JC; Toyoda M; Shibuya M Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584 [TBL] [Abstract][Full Text] [Related]
15. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo. Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180 [TBL] [Abstract][Full Text] [Related]
16. [Effect of recipient age, tumor immunogenicity and neonatal thymectomy on the appearance of the phenomenon of tumor growth inhibition in newborn mice]. Karmanova NV Vestn Akad Med Nauk SSSR; 1980; (5):67-74. PubMed ID: 7395341 [No Abstract] [Full Text] [Related]
17. The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5'-nucleotidase in rat hearts. Sato T; Obata T; Yamanaka Y; Arita M Br J Pharmacol; 1997 Oct; 122(4):611-8. PubMed ID: 9375955 [TBL] [Abstract][Full Text] [Related]
18. Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin. Wang R; Zhang XW; Wang GQ; Chen XC; Tian L; Yang HS; Hu M; Peng F; Yang JL; He QM; Zhang W; Jiang Y; Deng HX; Wen YJ; Li J; Zhao X; Wei YQ Cancer Gene Ther; 2006 Oct; 13(10):940-7. PubMed ID: 16799469 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317 [TBL] [Abstract][Full Text] [Related]
20. Characterization of an ecto-5'-nucleotidase (EC 3.1.3.5) activity in intact trophozoites of Trichomonas gallinae. Borges FP; Gottardi B; Stuepp C; Larré AB; Tasca T; De Carli GA; Bonan CD Vet Parasitol; 2007 Jan; 143(2):106-11. PubMed ID: 16962709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]